United States: DOJ And SEC Charge Healthcare Executive With Trading On Negative Information Known At The Time Of Adopting Rule 10b5-1 Trading Plans - McDermott Will & Emery

On March 1, 2023, the US Department of Justice (DOJ) and the US Securities and Exchange Commission (SEC) charged a healthcare executive with insider trading based on material, non-public negative information known to the executive at the time he adopted two Rule 10b5-1 trading plans.